Sustained Response to Antiviral Therapy Prevents Esophageal Varices in Hepatitis C Patients with Cirrhosis
7-05-2010

Treating Hepatitis C in People with Compensated Cirrhosis Is Most Cost-effective Approach
7-02-2010

Rifaximin Reduces Encephalopathy Recurrence, Improves Quality of Life in People with Liver Cirrhosis
5-28-2010

Pegylated Interferon plus Ribavirin Works as Well in HIV/HCV Coinfected Patients with Cirrhosis
5-28-2010

Measurable Neurocognitive Impairment Persists after Episodes of Hepatic Encephalopathy in People with Liver Cirrhosis
5-11-2010

Interferon-based Therapy Less Effective for Hepatitis C Patients with Advanced Liver Fibrosis or Cirrhosis
4-9-2010

Sustained Virological Response to Interferon-based Therapy Slows Progression of Liver Cirrhosis in Hepatitis C Patients
11-24-09

Coffee Slows Progression of Liver Disease in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
10-23-09

Hepatitis C May Not Increase Mortality among Patients Who Are Not Coinfected, Do Not Drink Heavily, and Do Not Have Cirrhosis
9-25-09

Bone Loss and Vitamin D Deficiency Are Common among People with Liver Cirrhosis
9-01-2009

Diets High in Protein and Cholesterol May Increase Risk of Liver Cirrhosis and Cancer, while Carbohydrates May Be Protective
8-7-2009

Pegylated Interferon alfa-2b (PegIntron) Maintenance Monotherapy May Reduce Esophageal Varices in Hepatitis C Patients with Cirrhosis
5-5-09

Liver Disease Progression and Treatment Response in Latino and Asian Patients with Chronic Hepatitis C
12-12-08

Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation
6-10-08

Natural History of HCV-Related Cirrhosis after Liver Transplantation
5-08-08

Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis
3-11-08

Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy
2-05-08